Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Endocyte Inc (ECYT)

Endocyte Inc (ECYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,969,339
  • Shares Outstanding, K 82,090
  • Annual Sales, $ 70 K
  • Annual Income, $ -55,060 K
  • 60-Month Beta -0.01
  • Price/Sales 28,144.80
  • Price/Cash Flow N/A
  • Price/Book 5.67
Trade ECYT with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.68
  • Most Recent Earnings $-0.18 on 02/26/18
  • Latest Earnings Date 11/05/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -0.16
  • Number of Estimates 4
  • High Estimate -0.15
  • Low Estimate -0.17
  • Prior Year -0.18
  • Growth Rate Est. (year over year) +11.11%

Price Performance

See More
Period Period Low Period High Performance
1-Month
23.39 +2.57%
on 11/28/18
24.00 -0.04%
on 12/20/18
+0.42 (+1.78%)
since 11/20/18
3-Month
14.50 +65.45%
on 10/11/18
24.00 -0.04%
on 12/20/18
+6.36 (+36.07%)
since 09/20/18
52-Week
2.81 +753.74%
on 02/06/18
24.00 -0.04%
on 12/20/18
+19.69 (+457.91%)
since 12/20/17

Business Summary

Endocyte, Inc. is a biopharmaceutical company engaged in the development of therapies for the treatment of cancer and inflammatory diseases. The Company creates novel small molecule drug conjugates (SMDCs) and companion imaging diagnostics for personalized targeted therapies. Endocyte, Inc. is based...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 24.00
1st Resistance Point 24.00
Last Price 23.99
1st Support Level 23.99
2nd Support Level 23.98
3rd Support Level N/A

See More

52-Week High 24.00
Last Price 23.99
Fibonacci 61.8% 15.91
Fibonacci 50% 13.40
Fibonacci 38.2% 10.90
52-Week Low 2.81

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar